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Abstract
Background The majority of patients presenting with suspected clinical cauda equina syndrome (CES) have no identifiable 
structural cause for their symptoms (‘scan-negative’ CES). Understanding these patients aids clinical differentiation and 
management in CES.
Methods A retrospective electronic note review was undertaken of patients presenting with suspected CES, defined as ≥ 1 
of acute bladder, bowel, sexual dysfunction or saddle numbness, to a regional neurosciences centre. We investigated radiol-
ogy, clinical features, psychiatric and functional disorder comorbidities and outcome of patients with ‘scan-negative’ CES 
and patients with MRI confirmed compression of the cauda equina (‘scan-positive’ CES).
Results 276 patients were seen over 16 months. There were three main radiologically defined patient groups: (1) ‘scan-
positive’ CES (n = 78, mean age 48 years, 56% female), (2) ‘scan-negative’ CES without central canal stenosis but with 
lumbosacral nerve root compression not explaining the clinical presentation (n = 87, mean age 43 years, 68% female) and 
(3) ‘scan-negative’ CES without neural compromise (n = 104, mean age 42 years, 70% female). In the two ‘scan-negative’ 
groups (no neural compromise and nerve root compression), there were higher rates of functional disorders (37% and 29% 
vs. 9%), functional neurological disorders (12% and 11% vs 0%) and psychiatric comorbidity (53% and 40% vs 20%). On 
follow-up (mean 13–16 months), only 1 of the 191 patients with ‘scan-negative’ CES was diagnosed with an explanatory 
neurological disorder (transverse myelitis).
Conclusions The data support a model in which scan-negative cauda equina syndrome arises as an end pathway of acute 
pain, sometimes with partly structural findings and vulnerability to functional disorders.
Keywords Cauda equina syndrome · Functional neurological disorder · Psychogenic · Chronic pain · Outcome · Negative 
scan
Introduction
Cauda equina syndrome (CES) is a devastating medical 
emergency caused by compression of the cauda equina 
nerve roots which without timely surgery results in blad-
der, bowel and sexual dysfunction with potential lower 
limb weakness and numbness [1]. Diagnosis is based on 
the clinical picture and MRI findings of cauda equina nerve 
root compression (‘scan-positive’ CES). However, at least 
half of all patients presenting with the acute clinical CES 
phenotype (acute bladder, bowel and sexual dysfunction, 
saddle anaesthesia and pain) have no radiological correlate, 
so-called ‘scan-negative’ CES. A systematic review of the 
correlation between history, physical examination and MRI 
scan result found that the mean prevalence of patients having 
both clinical and radiological evidence of CES was 14–48% 
with no single individual sign or symptom being helpful in 
diagnosing CES [2]; senior neurosurgical trainees asked to 
predict who would have a positive scan based on history and 
clinical findings had an accuracy of only 56% [3].
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article (https ://doi.org/10.1007/s0041 5-018-9078-2) contains 
supplementary material, which is available to authorized users.
 * Ingrid Hoeritzauer 
 Ingrid.hoeritzauer@ed.ac.uk
Extended author information available on the last page of the article
2917Journal of Neurology (2018) 265:2916–2926 
1 3
There has been little descriptive study of the ‘scan-nega-
tive’ CES group but a better understanding of their presenta-
tion may aid clinical differentiation and management. Based 
on our clinical experience and an initial pilot study of 18 
patients from a different centre which demonstrated Hoo-
ver’s sign of functional leg weakness in 82% of patients with 
‘scan-negative’ CES and 0% of patients with ‘scan-positive’ 
CES, we hypothesised that some patients with ‘scan-nega-
tive’ CES would have evidence of a functional disorder and 
this may explain at least some of their clinical presentation 
[4]. By a functional disorder we mean a disorder which is 
genuine but which is due to an abnormality of nervous sys-
tem functioning rather than of structure [5]. Functional neu-
rological disorders describe symptoms of abnormal motor 
and sensory function such as limb weakness or numbness, 
but does not include chronic pain, even when that is unre-
lated to a structural cause. Common examples of functional 
disorders are irritable bowel syndrome and functional neuro-
logical disorders. We investigated the radiological findings, 
demographics, clinical features, comorbidity and outcomes 
of a retrospective consecutive series of patients referred 
to a tertiary neurosurgery centre with suspected clinical 
cauda equina syndrome. Our aims were to better phenotype 
patients with ‘scan-negative’ CES, to test our hypothesis that 
at least some patients had evidence of a functional disorder 
and to generate hypotheses about how functional disorders, 
medication, pain with or without nerve root compression 
may interact to explain the bladder symptoms that cause 
patients to present acutely with ‘scan-negative’ CES.
Materials and methods
Definitions
Clinical CES was defined using the Fraser et al. criteria for 
CES: one or more of bladder, bowel, sexual dysfunction or 
saddle numbness ± lower limb neurological deficit [1].
Radiological cauda equina compression was defined as 
> 75% canal stenosis or lack of CSF around the cauda equina 
nerve roots [6]. ‘Impending’ CES was defined as (a) Fraser 
et al. clinical criteria, (b) an MRI scan showing a compres-
sive lesion which was large enough to compress the cauda 
equina nerve roots but which did not meet our radiological 
criteria and (c) the opinion of the consultant neurosurgeon 
that the compressive lesion was causing the clinical symp-
toms and would progress to irreversible CES unless urgently 
treated.
Patients were defined as with ‘scan-positive’ CES if 
they had both clinical and radiological evidence of CES or 
‘impending’ CES based on the definitions above. Patients 
were defined as ‘scan-negative’ CES if they satisfied the 
Fraser et al. criteria, had an urgent MRI scan for possible 
CES and had no evidence of radiological cauda equina com-
pression on their MRI.
Methods
Recruitment
In July 2016, we carried out a retrospective electronic record 
review of consecutive referrals with possible cauda equina 
syndrome to our regional neurosurgery service in Edinburgh 
between August 2013 and November 2014 with electronic 
note follow-up until July 2016. Consecutive neurosurgical 
referrals documented as possible cauda equina syndrome 
were reviewed manually by two of the authors (IH, SP). 
Patients were only included in the study if they met clini-
cal criteria for CES. All patients with ‘scan-positive’ CES 
were included as they were all assessed in the local health 
board, NHS Lothian, and had clinical symptoms, comorbidi-
ties and follow-up outpatient appointments recorded in NHS 
Lothian. Many patients referred to the neurosurgery service 
were from other NHS Scotland regions with a different elec-
tronic note record which was not possible to access centrally 
and were not seen in NHS Lothian; these patients were not 
included. To ensure that clinical data and follow-up were 
as complete as possible, patients with ‘scan-negative’ CES 
were only included if referred from an address within the 
local health board with NHS Lothian documentation of their 
signs and symptoms or referred via the local health board 
accident and emergency department. The study received 
local ethical approval from NHS Lothian (Caldiott Guard-
ian ref 1594).
Measures
With respect to the initial admission, all patients had urgent 
MRI lumbosacral scans which included the cauda equina 
down to the S5 foramina of the sacrum. A local protocol dic-
tates that a T2 sagittal of cervical and thoracic spine should 
be done if the MRI lumbosacral spine is normal. All scans 
were reported by a consultant neuroradiologist.
Using a standardised proforma, we assessed the radio-
logical features, demographics, clinical symptoms and 
signs, completeness of clinical documentation, and timing 
of operation (urgent: classified as during the initial admis-
sion; elective: classified as after discharge but scheduled due 
to symptoms and radiology from admission).
We carried out follow-up using electronic records until 
July 2016 by interrogating scan requests, accident and 
emergency attendances, all secondary care inpatient and 
outpatient visits. Information was obtained on functional 
disorder comorbidity (fibromyalgia; irritable bowel syn-
drome; chronic fatigue syndrome; non-cardiac chest pain); 
functional neurological disorders (as defined in DSM 5 
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including functional motor disorders and non-epileptic sei-
zures); psychiatric comorbidity (such as anxiety/depression/
post-traumatic stress disorder (PTSD)/personality disorder/
obsessive compulsive disorder(OCD)/suicidal ideation 
or deliberate overdose/anorexia nervosa); the presence of 
chronic pain documented in letters; urological symptoms; 
re-presentations with clinically suspected CES and new 
diagnoses which explained suspected CES presentation 
in patients with ‘scan-negative’ CES. When patients had 
urological symptoms documented during their follow-up, 
electronic notes were retrospectively reviewed back to 2009 
to accurately document the onset of urological symptoms.
Statistics
Statistics used were Chi-squared or Fisher’s exact two-sided 
testing for all symptoms, signs, comorbidities and outcomes. 
ANOVA was used for comparing mean ages. Statistics were 
carried out using Statsdirect (http://www.stats direc t.com). 
All P values are comparisons between one of the ‘scan-
negative’ groups and the ‘scan-positive’ group.
Results
276 patients were referred with clinically suspected cauda 
equina syndrome between August 2013 and November 2014 
(Table 1 and Supplementary Figure 1).
Radiological and demographic findings
During initial admission, seven patients were found to have 
alternate neurological causes mimicking or causing sacral 
nerve dysfunction: two patients had evidence of demyeli-
nation on MRI of their thoracic cord and both were sub-
sequently diagnosed with multiple sclerosis; two patients 
had infections causing bladder or sacral symptoms [urinary 
retention due to urosepsis (n = 1) and systemic infection 
with abscess at L2/3 (n = 1)]; three patients had CES mim-
ics [thoracic subdural haematoma (n = 1), L1 lumbar fracture 
(n = 1) and metastatic epidural deposit causing thoracic cord 
compression (n = 1)]. We excluded these seven patients from 
further analysis.
Patients were divided into three main radiological groups:
• 78 had ‘scan-positive’ clinico-radiological CES, includ-
ing ‘impending’ CES (mean age 48 years (range 21–91), 
56% female).
• 87 had ‘scan-negative’ CES but with nerve root compres-
sion of at least one nerve root L3–S2 [mean age 43 years 
(range 20–79), 68% female]. We separated this group on 
the grounds that some L3–S2 nerve root compression 
would not have caused sphincter dysfunction but may 
have impacted on bladder function or promoted func-
tional motor/sensory symptoms in the legs.
• 104 had ‘scan-negative’ CES without neural compromise 
[mean age 42 years (range 16–81), 70% female].
We will continue with these subdivisions: ‘scan-positive’ 
CES, ‘scan-negative’ CES with root compression and ‘scan-
negative’ CES without neural compression, throughout the 
rest of the paper.
‘Scan‑positive’ diagnoses and surgical timing
Of the 78 patients with ‘scan-positive’ CES, 67 (86%) were 
caused by disc protrusion, the other 11 had various lesions 
compressing the cauda equina nerve roots: n = 4 fractures, 
n = 4 had metastatic deposits, n = 1 fracture and a metastasis, 
n = 1 a primary tumour and n = 1 large cyst.
68 patients (87%) with ‘scan-positive’ CES had an emer-
gency operation, seven were treated conservatively (n = 2 too 
unwell, n = 2 symptoms > 1 week and resolving, n = 2 meta-
static deposits, n = 1 vertebral fracture). In three of these 
patients sphincter symptoms of CES either turned out to 
have another cause or resolved but the patients were operated 
on electively anyway for leg pain.
Sixteen patients with ‘scan-negative’ CES had an opera-
tion, 2 urgently, both of whom had nerve root compression 
and severe pain which did not settle after admission, and 14 
electively for leg pain.
Clinical features
Urinary function (n = 263, 98%), lower limb pain (n = 250, 
93%) saddle sensation (n = 247, 92%), lower limb power 
(n = 229, 85%) and sensation (n = 225, 84%) were often 
documented. Bowel function (n = 177, 66%), anal tone from 
digital rectal examination (n = 151, 56%) and sexual function 
(n = 14, 5%) were poorly or very poorly documented.
Symptoms
Patients with scan-positive CES were more likely to have 
symptoms of bilateral sciatica and, surprisingly, were less 
likely to have documented bladder dysfunction than patients 
in either of the ‘scan-negative’ CES groups (see Table 1). 
These are two controversial findings so we reviewed them 
in detail. Even when both ‘scan-negative’ groups were com-
bined bilateral sciatica was still significantly more likely in 
patients with ‘scan-positive’ CES’ (38% vs. 20%, n = 30/78 
vs. n = 39/191, P = 0.002). The patients with normal bladder 
function met our criteria as ‘impending’ cauda equina syn-
drome. These patients all had radiological evidence of cauda 
equina compression and one or more other signs of clinical 
cauda equina syndrome, most commonly saddle numbness, 
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Table 1  Clinical features of scan-positive and -negative cauda equina syndrome
Scan +ve (n = 78)
n (%)
Scan −ve with root 
compression (n = 87)
n (%)
P value Scan −ve no root com-
pression (n = 104)
n (%)
P value
Age (mean, SD) 48 years ± 16.8 43 years  ± 12.1 42 years ± 12.6
Gender 56% female 68% female 70% female
Operation
Emergency 68 (87%) 2 (2%) 0
Elective 3 (4%) 12 (14%) < 0.001 2 (2%) < 0.001
Bladder symptoms
Storage problems
 Incontinence 17 (22%) 20 (23%) 42 (40%)
 Urgency/frequency 0 3 (3%) 1 (1%)
Voiding problems
 Retention 16 (20%) 21 (24%) 26 (25%)
 Reduced awareness 4 (5%) 6 (7%) 3 (3%)
 Hesitancy/difficulty passing 15 (19%) 18 (21%) 11 (11%)
 Mixed problems 0 3 (3%) 11 (11%) 0.01
 Normal 22 (28%) 15 (17%) 9 (9%) 0.0005
Bowel symptoms
Incontinence 6 (8%) 14 (16%) 13 (12%)
1 chronic
Constipation 11 (14%) 8 (9%) 11 (11%)
Reduced awareness 1 2 (2%) 2 (2%)
Normal 27 (35%) 39 (45%) 42 (40%)
Sexual function
Abnormal 6 (8%) 4 (5%) 2 (2%)
Normal 0 (0%) 2 (2%) 0
No info 72 (92%) 81 (93%) 102 (98%)
Sciatica
Yes 69 (88%) 75 (86%) 80 (77%)
Bilateral sciatica 32 (41%) 17 (20%) < 0.001 22 (21%) 0.001
No 5 (6%) 7 (8%) 12 (11%)
Other leg pain 0 1 (1%) 3 (3%)
Weakness
Yes 35 (45%) (bilateral 13) (17%) 43 (49%) (bilateral = 12) 
(14%)
52 (50%) (bilateral 19) 
(18%)
No weakness 26 (33%) 37 (42%) 36 (35%)
Leg numbness
Nerve root distribution 48 (61%) 24 (28%) < 0.001 38 (36%) < 0.001
Bilateral root numbness 18 (23%) 4 (5%) 13 (12%)
Whole leg 1 (1%) 8 (9%) 9 (9%)
No numbness 6 (8%) 20 (23%) 0.01 17 (16%)
Non-dermatomal numbness 2 (2%) 16 (18%) 0.001 16 (15%) 0.004
Saddle numbness* 50(64%) 47 (54%) 0.04 54 (52%) 0.02
Normal 18 (23%) 35 (40%) 42 (40%)
Digital rectal exam
Reduced anal tone 14 (18%) 18 (21%) 19 (18%)
Normal 17 (22%) 39 (45%) 44 (42%)
1 refused (1%)
Post-void residual
< 100 mls 5 (6%) 14 (16%) 12 (9%)
> 100–500 mls 7 (9%) 11 (13%) 5 (5%)
> 500 mls 3 (4%) 2 (2%) 6 (6%)
No info 63 (81%) 60 (69%) 81 (78%)
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documented in twenty patients or bowel or sexual dysfunc-
tion in four patients each.
Signs
Patients with ‘scan-positive’ CES were more likely to have 
saddle numbness (64% vs 54% and 52%, P = 0.04, 0.02), 
although rates were relatively high (> 50%) in all groups.
Comorbidity functional and psychiatric disorders
Both patient groups with ‘scan-negative’ CES were more 
likely to have a comorbid functional disorder, functional 
neurological disorder and psychiatric diagnoses than patients 
with ‘scan-positive’ CES when assessed at follow-up in July 
2016 (see Table 2). The specificity of finding a comorbid 
functional neurological disorder in ‘scan-negative’ CES at 
presentation was 1 (0.95–1) although sensitivity was low, 
0.09 (6–14).
Outcomes: pain, re‑presentation rate, and bladder 
function
There were no significant differences between the three 
groups in the follow-up frequency (93% vs. 89% and 87%) or 
mean duration of follow-up (average 13 months, 16 months, 
16 months) (Table 3).
Table 1  (continued)
Bold—P values of < 0.05 were deemed significant
P values refer to comparison against scan-positive group and are only shown if significant
SD standard deviation
*Saddle numbness: as assessed by pin prick sensation
Table 2  Functional and psychiatric comorbidity in scan-positive and -negative cauda equina syndrome
Bold—P values of < 0.05 were deemed significant
FND functional neurological disorder, OCD obsessive compulsive disorder, PTSD post-traumatic stress disorder
*Several patients had more than one disorder
Scan +ve (n = 78)
n (%)
Scan −ve with root 
compression (n = 87)
n (%)
P value Scan −ve no root compression (n = 104)
n (%)
P value
Functional disorder comorbidity 7 (9%) 26 (30%) 0.0007 39 (37%) < 0.0001
Functional disorders*
Irritable bowel syndrome 2 (3%) 9 (10%) 12 (11%)
Non-cardiac chest pain 0 7 (8%) 17 (16%)
Chronic widespread pain 5 (6%) 5 (6%) 8 (8%)
Other 1 atypical facial pain 2 functional cognitive disorder
Functional neurological disor-
ders*
0 10 (11%) 0.0014 13 (12%) 0.0005
Limb weakness 3 (3%) 6 (6%)
Sensory/hemisensory 4 (5%) 5 (5%)
Dissociative seizures 2 (3%) 1 (1%)
Other 2 (2%) Dysphonia 2 (2%) Visual
Psychiatric diagnoses*
Depression 17 (22%) 34 (39%) 0.02 55 (53%) < 0.0001
Anxiety 14 (18%) 26 (30%) 43 (41%)
Personality disorder 8 (10%) 21 (24%) 17 (16%)
Other 0 2 (2%)
1 anorexia
1 OCD
1 suicidal ideation
1 (1%)
3 (3%) PTSD
2 deliberate overdose
Timing of FND in relation to CES presentation
Prior 6 (7%) 6 (6%)
At the same time 2 (2%) 4 (4%)
After 2 (2%) 3 (3%)
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Only one patient in the scan-negative groups presented 
at follow-up with an alternative neurological explanation 
for CES. This patient had transverse myelitis. They had no 
comorbid functional disorders.
Four patients with ‘scan-positive’ CES (4%) re-presented 
during the study time with a new episode of clinical cauda 
equina syndrome, two of whom required re-operation. Re-
presentations with possible cauda equina syndrome neces-
sitating an urgent scan during follow-up occurred in 22 of 
the 191 patients (11%) with ‘scan-negative’ CES, all of 
whom continued to have negative scans. Fifteen patients 
re-attended once, five re-attended twice and two patients 
re-attended three times (see breakdown in Table 3). Only 
5 patients (23%) re-presented within 1 month suggesting 
their recurrent presentations related to 1 episode of ongoing 
symptoms, the other 17 presented over a longer period sug-
gesting multiple different episodes of symptom occurrence.
Patients with ‘scan-negative’ CES in both groups were 
more likely to have chronic pain recorded in the electronic 
patient record on follow-up (26% vs 58% and 59%).
Rates of bladder dysfunction in the electronic patient 
record were not significantly different in all groups. Pre-
existing bladder symptoms were found in two patients with 
‘scan-positive’ CES, one patient within the ‘scan-negative’ 
Table 3  Follow-up and outcomes
Bold—P values of < 0.05 were deemed significant
Scan +ve (n = 78)
n (%)
Scan −ve with root com-
pression (n = 87)
n (%)
P value Scan −ve no root compression 
(n = 104)
n (%)
P value
Average follow-up/months 13 16 16
No follow-up 10 (13%) 6 (7%) 12 (11%)
Deceased or palliative 4 1
Cause of clinical CES found 100% 0 1 (1%)
Re-presentation with clinical CES
Once 3 (4%) 10 (11%) 12 (11%)
Twice 3 (4%) 8 (9%) 7 (7%)
Three times N/A 2 (2%)
2 (2%)
3 (3%)
2 (2%)
3 (3%)
Prior ‘scan-positive’ CES 2 (3%) 3 (3%) 2 (2%)
Prior ‘scan-negative’ CES 6 (7%) 9 (9%)
Chronic pain 20 (27%) 52 (60%) < 0.0001 60 (58%) < 0.0001
Bladder disorders
Total affected 8 (10%) 8 (9%) 11 (11%)
Storage problems
 Neurogenic bladder 7 (9%) 0 0
 Overactive bladder 1 (1%) 1 (1%) 1 (1%)
 Stress incontinence 1 (due to prolapse) 0
 Urge incontinence 0 2 (2%)
Voiding problems
 Idiopathic urinary retention 1 (1%) 3 (3%)
 Urethral stenosis 1(1%) 2 (2%)
 BPH 1 (1%) 1(1%)
Other 1 (1%)UTI
2 idiopathic haematuria
1 bladder outlet obstruction
1 enuresis
Timing of urological diagnoses
Before CES presentation
Stress urinary incontinence 2 (3%) 1 (1%) 4 (4%)
Urge incontinence 1 (1%) 2 (2%)
Idiopathic urinary retention 1 (1%) 1 (1%)
Bladder outlet obstruction 1 (1%) 1 (1%)
At time of diagnosis 0 1 (1%) UTI 0
After CES presentation 6 (8%) 6 (7%) 7 (7%)
2922 Journal of Neurology (2018) 265:2916–2926
1 3
CES with root compression group and in four patients in 
the ‘scan-negative’ without neural compression group. One 
patient from each group had prior episodes of urinary reten-
tion. After CES presentation, idiopathic urinary retention 
affected one person in the ‘scan-negative’ with root compres-
sion group and three patients without neural compression.
Discussion
We found that patients with ‘scan-positive’ and ‘scan-neg-
ative’ CES presented with similar core symptoms. Saddle 
anaesthesia and bilateral sciatica with radicular sensory 
abnormalities were common in patients with ‘scan-posi-
tive’ CES, whilst non-dermatomal sensory loss and mixed 
urinary problems were more commonly seen in patients 
with ‘scan-negative’ CES. However, as in previous studies, 
no individual clinical symptom or sign could accurately 
differentiate between scan-positive and ‘scan-negative’ 
CES [7]. The explanation for scan-negative CES does not 
appear to be latent neurological disease, of which there are 
many causes (Table 4) [8–19], at least in the majority of 
patients, since we only found one patient where this was 
the case at follow-up.
The neurological differential diagnoses for ‘scan-nega-
tive’ CES were considered by the authors and encompasses 
inflammatory, infectious, vascular, neoplastic and neuro-
degenerative disorders (Table 4). In some cases, these 
conditions can be difficult to diagnose and may present 
initially as peripheral disorders but are caused by central 
mechanisms. This is particularly the case in patients with 
arteriovenous malformations including dural AV fistula 
[15]. Patients may present several times prior to diagno-
sis but symptoms are progressive and ultimately upper 
motor neurone signs appear. Transient infectious causes 
of lumbosacral polyradiculitis, such as Elsberg syndrome, 
caused by HSV, may also be difficult to pick up as lumbar 
puncture results normalise quickly and can have poor posi-
tive predictive value [12]. In a recent study at the Mayo 
clinic, five patients over a 16-year period were felt to have 
Elsberg syndrome causing cauda equina radiculitis [12]. 
Bladder symptoms affect approximately 75% of patients 
with multiple sclerosis and are often cited as one of the 
most unpleasant symptoms by patients [8]. However, it 
is unusual for patients to present with bladder symptoms 
only and the diagnosis of multiple sclerosis is based upon 
clinical events and lesions separated in time and space.
In keeping with our hypothesis, patients with ‘scan-neg-
ative’ CES did have notably more functional somatic disor-
ders, psychiatric comorbidity and especially functional neu-
rological disorders than patients with scan-positive CES who 
had similar sphincter and leg symptoms. The specificity for 
functional neurological disorders in this scenario for ‘scan-
negative’ CES was 1 (0.95–1) although sensitivity was 0.12 
(7–17) with around half of patients developing their func-
tional neurological disorders during their ‘scan-negative’ 
CES presentations (Table 2).
The data support our earlier pilot study and strongly sug-
gest that at least some patients with ‘scan-negative’ CES 
have symptoms due to acute functional limb weakness, 
Table 4  Uro-neurological differential diagnoses of clinical cauda equina syndrome with normal MR imaging
Urinary retention Urinary incontinence
Neurological differential diagnoses*
 Inflammation Myelitis Multiple sclerosis [8]
Myelitis especially neuromyelitis optica spectrum 
disorder [9]
 Infectious Elsberg’s syndrome [12], varicella zoster, cytomeg-
alovirus, herpes simplex, HIV [13, 14]
 Vascular Arteriovenous malformation [15], spinal infarction 
[16]
Cerebral stroke [17]
 Neoplastic Neoplastic or radiation induced [18]
 Neurodegenerative Multiple system atrophy [19] Parkinson’s disease [19]
Urological differential diagnoses Fowler’s syndrome [10]
Idiopathic urinary retention
Exacerbation of prior urinary incontinence (affects 
20% women over 40) [29]
Bladder pain syndrome [11]
Medications (side effects recorded 
from the British National Formu-
lary)
Opiates
Anticholinergics (e.g. tricyclics)
Benzodiazepines
NSAIDs (risk increases in elderly and with higher 
doses)
Benzodiazepines
Pregabalin
SSRIs
ACE inhibitors/diuretics
Other possibilities Pain: radiculopathy is a common comorbidity
Many cervico/thoracic pathologies can lead to cauda equina symptoms
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numbness and functional, pain or medication-related urinary 
symptoms. Our findings are in keeping with other studies 
showing functional neurological disorders are commonly 
triggered by pain. For example, a systematic review of 869 
patients with functional motor and sensory symptoms found 
that physical injury preceded onset in 37% cases [20, 21]. In 
the last 10 years, the understanding and awareness of func-
tional neurological disorders has increased significantly. 
Diagnosis is made on the basis of positive clinical signs, 
such as Hoover’s sign of functional leg weakness—weak-
ness of hip extension which normalises with contralateral 
hip flexion, which has good diagnostic sensitivity and speci-
ficity [22]. A positive diagnosis and tailored physiotherapy 
seems to be more effective for functional motor disorder 
than standard treatment with 72% of patients improving in a 
recent randomised trial compared to only 18% of the control 
group [23]. Understanding of the mechanism of functional 
neurological disorders has expanded from Freudian ideas 
of conversion to Bayesian ideas of ‘top-down’ expectation 
and abnormal self-directed attention overriding the normal 
sensory and motor pathways [24, 25].
Psychiatric disorders are not uncommon in the popula-
tion; however, levels of 40 or 50% are higher than would be 
expected even in patients with chronic neurological disease 
[26] and in higher than psychiatric comorbidity in some 
studies of patients with chronic back pain [27]. Patients with 
avoidance and panic are more likely to develop chronic pain 
so knowledge and appropriate treatment of these comorbidi-
ties are important [28]. Urological symptoms requiring urol-
ogy input were similar in both groups. This is noteworthy 
given that urological symptoms are one of the most com-
mon reasons why patients with ‘scan-positive’ CES must be 
urgently operated on. High numbers of patients in the ‘scan-
negative’ groups represented with clinical CES requiring an 
urgent scan which was always negative. This suggests that 
not only are patients having recurrent symptoms which cor-
relate with clinical CES, as per the Fraser et al. criteria, but 
that they are also high-resource users and we should make 
more effort to understand and treat them.
Hypothetical mechanisms for ‘scan‑negative’ CES
The excess of abnormal bladder symptoms in the patients 
with ‘scan-negative’ CES was of particular interest and 
potentially counters many clinicians’ expectations. There 
are several possible hypotheses about the origin of bladder 
symptoms in patients with ‘scan-negative’ CES. First, pain 
causing sympathetic hyperactivity and increased inhibi-
tory signals via the hypogastric and pelvic nerves could be 
resulting in increased contraction of the internal urethral 
sphincter and override normal voiding parasympathetic 
processes causing difficulty voiding. Second, pain or panic 
may have exacerbated underlying bladder dysfunction 
including incontinence which occurs in up to one-fifth of 
middle-aged women [29] and is more common in patients 
with anxiety and depression [30] or chronic back pain 
[31]. Third, analgesic medications have significant effects 
on the bladder. Medications such as pregabalin, gabapen-
tin and benzodiazepines can cause or exacerbate urinary 
incontinence [32, 33]. Opiates are well known to affect 
the bowels but the effect on the bladder, which if severe 
can lead to chronic urinary retention, is less well recog-
nised [34]. Opiates can also cause severe constipation and 
there is a case report of constipation causing pelvic nerve 
entrapment and mimicking cauda equina syndrome [35]. 
From the authors’ experience, it is much more common 
that patients are constipated from medications and this 
results in more pain and difficulty passing a bowel motion. 
Fourth, a cause of chronic urinary retention triggered by 
pain or medications is Fowler’s syndrome, which describes 
primary failure of the external urethral sphincter to relax. 
Patients with Fowler’s syndrome have high rates of chronic 
pain and functional neurological disorder comorbidity 
[36]. Fowler’s syndrome has detectable neurophysiological 
changes and its aetiology remains uncertain but one pos-
sibility is that it represents a primary functional disorder 
of the urethral sphincter and a chronic model of the type 
of retention or voiding dysfunction seen in some patients 
with scan-negative cauda equina. Finally, previous studies 
of patients presenting for routine lumbar decompression 
found bladder symptoms in 55% [37] and an additional 
urodynamics study of a similar patient group found 26% 
had urodynamic evidence of detrusor areflexia all of whom 
reported abdominal straining to void [38]. This may be 
due to downstream effects of compression or inflamma-
tion from higher nerve roots; however, there was only 
one patient with idiopathic urinary retention in the ‘scan-
negative’ with root compression group on follow-up, so 
this explanation seems unlikely to be a major cause of 
symptoms in the ‘scan-negative’ groups.
Considering these ideas, we propose that at least some 
patients with scan-negative CES patients can be best 
understood to have a functional disorder explaining some, 
or all, of their presentation. We hypothesise that many 
patients have a vulnerability either to functional disorder 
and/or a prior underlying bladder dysmotility disorder. In 
some cases, patients may respond to severe back muscle 
spasm or pain from disc herniation and nerve root entrap-
ment with panic and dissociation > resulting in either 
inability to contract the pelvic floor causing incontinence 
or inability to relax the pelvic floor and urethral sphincter 
causing urinary retention. Acute or long-term analgesia 
such as opiates may cause further retention, or gabapenti-
noids may cause incontinence, worsening the bladder dys-
function. Patients then present to hospital with clinical 
CES where they typically receive reassurance (although 
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no explanation for why they had sphincter symptoms), 
pain relief and physiotherapy. However, for the 50% who 
develop chronic pain and the 11% who have recurrent epi-
sodes of suspected CES, fear of movement and an atten-
tional focus of symptoms may lead to deconditioning and a 
centrally generated pain syndrome with consequent inabil-
ity to return to normal activity.
Limitations
The retrospective nature of the study and its dependence on 
electronic notes resulted in missing data. The design means 
that data about clinical features were not collected through 
routine practice and not systematically. This may explain 
our potentially controversial findings of bilateral sciatica 
being more common in patients with ‘scan-positive’ CES, 
although we think this is unlikely, especially given the high 
rate of symptom documentation (95%). Patients with ‘scan-
positive’ CES, including those with ‘impending’ CES, were 
more likely to have normal bladder function than patients 
with ‘scan-negative’ CES which also was an unexpected 
finding of our study. The high frequency of missing data 
about sexual function was surprising and may be important 
in differentiating ‘scan-positive’ from ‘scan-negative’ CES. 
Not all patients with normal radiology saw a neurologist, for 
example, if they were discharged quickly. This means that 
functional comorbidity may have been underestimated. All 
patients with ‘scan-positive’ CES from South East Scotland 
were included whereas only ‘scan-negative’ CES patients 
from a smaller area (NHS Lothian) with complete medi-
cal records were included; hence, this study cannot be used 
to estimate CES incidence or compare incidence of ‘scan-
positive’ vs. ‘scan-negative’ CES. However, this limitation 
means that scan-negative CES is likely to be even more 
common than we have demonstrated in this study. Medica-
tion records were not accurate enough for inclusion in the 
study and this is a gap in the data. Primary care data about 
outcome on follow-up were not available and this may lead 
to an underestimation of urological or pain symptoms dur-
ing follow-up in all groups. Some additional neurological 
diagnoses may have been missed; however, our departmen-
tal policy of a T2 sagittal MRI of the thoracic and cervical 
spine for lumbosacral scan-negative CES identified seven 
patients who immediately obtained a non-CES diagnosis. 
Only one additional diagnosis was found on follow-up at 16 
months with 88% follow-up, and among the 22 patients who 
re-attended and were investigated again for ‘scan-negative’ 
CES, no new diagnoses were made. This suggests that alter-
native neurological diagnoses are unlikely to explain a high 
proportion of scan-negative CES. We believe immediate 
investigation and diagnosis is one of the reasons there was 
only one new diagnosis at follow-up.
Conclusion
We found that of 276 consecutive CES patients, 28% 
(n = 78/276) were ‘scan positive’, 69% (n = 191/276) were 
‘scan negative’ and 3% (n = 7/276) had an alternative cause 
mimicking or causing sacral nerve dysfunction. There was 
no single clinical feature which differentiated between 
the groups. Of the scan-negative patients, just under half 
of patients had a nerve root compression that may have 
contributed but did not explain their clinical presentation. 
These patients with ‘scan-negative’ CES were more likely 
to have comorbid psychiatric and functional disorders and 
have chronic pain on follow-up. The data support a model in 
which ‘scan-negative’ cauda equina arises as an end pathway 
of acute pain, sometimes with partly structural causes, medi-
cation side effects and vulnerability to functional disorder. 
A prospective study with systematically collected clinical 
data, additional imaging and neurological assessment would 
reduce these limitations.
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